The apolipoprotein E (APOE) ε4 variant is the strongest genetic risk factor for late-onset AD, while the ε2 variant has been shown to confer protection against AD, in a dose-dependent manner [2–4]. This evidence concerns the gene APOE and Alzheimer disease.